221 related articles for article (PubMed ID: 38247655)
1. Toxic Shock Syndrome: A Literature Review.
Atchade E; De Tymowski C; Grall N; Tanaka S; Montravers P
Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247655
[TBL] [Abstract][Full Text] [Related]
2. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
3. Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
Chuang YY; Huang YC; Lin TY
Paediatr Drugs; 2005; 7(1):11-25. PubMed ID: 15777108
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
5. Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.
Whiting JL; Rosten PM; Chow AW
Infect Immun; 1989 Jan; 57(1):231-4. PubMed ID: 2909490
[TBL] [Abstract][Full Text] [Related]
6. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
[TBL] [Abstract][Full Text] [Related]
7. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.
Schlievert PM; Jablonski LM; Roggiani M; Sadler I; Callantine S; Mitchell DT; Ohlendorf DH; Bohach GA
Infect Immun; 2000 Jun; 68(6):3630-4. PubMed ID: 10816521
[TBL] [Abstract][Full Text] [Related]
8. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
Schlievert PM
Antimicrob Agents Chemother; 2007 Sep; 51(9):3056-62. PubMed ID: 17576832
[TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects of streptococcal and staphylococcal toxinic diseases].
Floret D
Arch Pediatr; 2001 Sep; 8 Suppl 4():762s-768s. PubMed ID: 11582925
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Epidemiology of Staphylococcal Toxic Shock Syndrome in the United Kingdom.
Sharma H; Smith D; Turner CE; Game L; Pichon B; Hope R; Hill R; Kearns A; Sriskandan S
Emerg Infect Dis; 2018 Feb; 24(2):258-66. PubMed ID: 29350159
[TBL] [Abstract][Full Text] [Related]
11. Similarities and Differences Between Staphylococcal and Streptococcal Toxic Shock Syndromes in Children: Results From a 30-Case Cohort.
Javouhey E; Bolze PA; Jamen C; Lina G; Badiou C; Poyart C; Portefaix A; Tristan A; Laurent F; Bes M; Vandenesch F; Gilletand Y; Dauwalder O
Front Pediatr; 2018; 6():360. PubMed ID: 30547021
[No Abstract] [Full Text] [Related]
12. [Lethal, non-menstrual toxic shock syndrome associated with Staphylococcus aureus sepsis].
Raumanns J; Kaufhold A; Behrendt W; Peters G
Anaesthesist; 1995 Dec; 44(12):869-74. PubMed ID: 8594962
[TBL] [Abstract][Full Text] [Related]
13. Molecular structure of staphylococcus and streptococcus superantigens.
Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
[TBL] [Abstract][Full Text] [Related]
14. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
15. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
[TBL] [Abstract][Full Text] [Related]
16. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
17. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
Schlievert PM; Cahill MP; Hostager BS; Brosnahan AJ; Klingelhutz AJ; Gourronc FA; Bishop GA; Leung DYM
mBio; 2019 Mar; 10(2):. PubMed ID: 30890614
[TBL] [Abstract][Full Text] [Related]
19. Functional and Immunological Studies Revealed a Second Superantigen Toxin in Staphylococcal Enterotoxin C Producing
Roetzer A; Model N; Laube J; Unterhumer Y; Haller G; Eibl MM
Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136533
[No Abstract] [Full Text] [Related]
20. Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.
Lee VT; Chang AH; Chow AW
J Infect Dis; 1992 Oct; 166(4):911-5. PubMed ID: 1527429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
